Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro staphylococcus epidermidis biofilms

Indian Journal of Medical Research

Volumn 135, Issue 4, 2012, Pages 542-547

  Gomes, Fernanda ^a   Teixeira, Pilar ^a   Ceri, Howard ^b   Oliveira, Rosário ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antibiotics susceptibility; Biofilm; MBECTM assay; Staphylococcus epidermidis

Indexed keywords

CEFALOTIN; CEFAZOLIN; CLINDAMYCIN; GENTAMICIN; LEVOFLOXACIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CELL COUNT; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS;

BIOFILMS; CLINDAMYCIN; DRUG COMBINATIONS; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84861952362     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hellmark B, Unemo M, Nilsdotter-Augustinsson Å, Söderquist B. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin Microbiol Infect 2009; 15: 238-244.
2. Otto M. Staphylococcus epidermidis- the "accidental" pathogen. Microbiology 2009; 7: 555-567.
3. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003; 188: 706-718.
4. Hajdu S, Lassnigg A, Graninger W, Hirschl AM, Presterl E. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and cefriaxone on Staphylococcus epidermidis biofilms. J Orthop Res 2009; 27: 1361-1365.
5. Knobloch JK-M, von Osten H, Horstkotte MA, Rohde H, Mack D. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Med Microbiol Immunol 2002; 191: 107-114.
6. Cargill JS, Upton M. Low concentration of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. J Clin Pathol 2010; 62: 1112-1116.
7. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res 1997; 11: 160-167.
8. Mah T-FC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobials agents. Trends Microbiol 2001; 9: 34-39.
9. Gualtieri M, Bastide L, Villain-Guillot P, Michaux-Charachon S, Latouche J, Leonetti J. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2006; 58: 778-783.
10. Lyytikfinen O, Vaara M, Jfrviluoma E, Rosenqvist K, Tiittanen L, Valtonen V. Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur J Clin Microbiol Infect Dis 1996; 15: 133-138.
11. Monzón M, Oteiza C, Leiva J, Amorena B. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001; 48: 793-801.
12. Piette A, Verschraegen G. Role of coagulase-negative staphylococci in human disease. Ve t Microbiol 2009; 134: 45-54.
13. th ed. Approved Standard M7-A8. CLSI, Wayne, PA, USA; 2010.
14. Ceri H, Olson ME, Stremick C, Read RR, Morck DW, Buret AG. The Calgary bioflm device: new technology for rapid determination of antibiotic susceptibilities in bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
15. TM assay system. FEMS Microbiol Lett 2001; 203: 263-267.
16. Harrison JJ, Turner RJ, Joo DA, Stan MA, Chan CS, Allan ND, et al. Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008; 52: 2870-2881.
17. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in bioflm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005; 56: 331-336.
18. Wang X, Yao X, Zhu Z, Tang T, Dai K, Sadovskaya I, et al. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agents 2009; 34: 60-66.
19. Mick V, Domínguez MA, Tubau F, Liñares J, Pujol M, Martín R. Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228, Spain. BMC Microbiol 2010; 10: 68.
20. Zavasky DM, Sande MA. Reconsideration of rifampin: a unique drug for a unique infection. JAMA 1998; 279: 1575-1577.
21. Moellering RC. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46: 1032-1037.
22. Saginur R., St.Denis M., Ferris W., Aaron S.D., Chan F., Lee C. Multiple combination bactericidal testing of Staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: 55-61.
23. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacterial on vascular catheters. Antimicrob Agents Chemother 2007; 51: 1556-1558.